Hormonal responses to nasal application of synthetic gonadotropin-releasing hormone in amenorrheic patients pretreated with gonadotropins

Keyphrases

• Gonadotropin-releasing Hormone 100%
• Hormonal Response 100%
• Gonadotropins 100%
• Nasal Application 100%
• Luteinizing Hormone 50%
• Nasal Drop 50%
• Ovulation 33%
• Hormone Levels 33%
• Temperature Curve 33%
• Human Menopausal Gonadotropin 33%
• Follicular Maturation 33%
• Basal Body Temperature 33%
• Consecutive Days 16%
• Clinical Response 16%
• Long-term Treatment 16%
• Hormone Response 16%
• Uterine Bleeding 16%
• Therapeutic Value 16%
• Self-administration 16%
• Ovulatory 16%
• Intranasal 16%
• Progesterone Level 16%
• Upward Shift 16%
• First Dose 16%
• Anovulatory Infertility 16%
• Luteal Phase 16%
• Patient Plasma 16%
• Total Daily Dose 16%
• Plasma Progesterone 16%
• Alternative Route of Administration 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Gonadorelin 100%
• Gonadotropin 100%
• Nose Drops 50%
• Luteinizing Hormone 50%
• Human Menopausal Gonadotropin 33%
• Route of Administration 16%
• Uterus Bleeding 16%
• Progesterone 16%